ArticleOncology and therapy2024

Palbociclib in HR-Positive, HER2-Negative Advanced/Metastatic Breast Cancer: A Systematic Scoping Review of Real-World Evidence from Countries Outside of Western Regions that Are Underrepresented in Clinical Trials.

Amit Rauthan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.